Esphera SynBio

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$2M

Esphera SynBio develops cancer immunotherapies, vaccines, and immunomodulatory therapies using synthetic biology to engineer exosomes as nanomedicines.

Total Funding

$2M

Headquarters

Ottawa, Canada

Founded

N/A

Website

espherasynbio.ca

Focus Areas

Synthetic biology

cancer immunotherapies

vaccines

immunomodulatory therapies

exosomes

nanomedicines

Investors